摘要
目的 :评价在哮喘急性发作期沙丁胺醇和溴化异丙托品联合用药与单用沙丁胺醇的疗效。方法 :分两组 ,A组雾化吸入沙丁胺醇并溴化异丙托品 ,B组雾化吸入沙丁胺醇 ,两组共计 6 0例。评价两组的 PEF值及临床症状缓解。结果 :两组 PEF值 (最大呼气流速 )治疗后均高于治疗前 ,P<0 .0 1。A组 PEF值的改变明显高于 B组 ,P<0 .0 5。临床症状缓解评价 A组高于 B组 ,P<0 .0 1。结论
Objective:[WT5BZ]To compare the bronchodilatation effects of nebulized Ipratropium Bromide and Ventolin with Ventolin alone on children with asthma.[WT5HZ]Methods:[WT5BZ]60 asthmatic children were divided into group A and group B.The former received nebulized Ipratropium Bromide and ventolin.The latter ventolin alone.PEF value and symptoms were evaluated before and after treatment.[WT5HZ]Results:[WT5BZ]PEF value increased in both groups after treatment.But PEF value in group A was higher than that in group B.Symptoms relief was quicker in group A.[WT5HZ]Conclusion:[WT5BZ]Bronchodilatation effect of nebulized Ipratropium Bromide and Ventolin was better than Ventolin alone.
出处
《河北医学》
CAS
2000年第6期520-522,共3页
Hebei Medicine
关键词
哮喘
沙丁胺醇
溴化异丙托品
联合用药
WT5BZ]Asthma
Ventolin(Salbutamel)
Ipratropium Bromide(Atrovent)
